Rx Medicare

Medicare News

Flower

Posts Tagged ‘tamiflu’

Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu

If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it…

Read More…

  • Share/Bookmark

Toward A Less Expensive Version Of The Anti-flu Drug Tamiflu

Scientists have developed an alternative method for producing the active ingredient in Tamiflu?, the mainstay for fighting H1N1 and other forms of influenza. The new process could expand availability of the drug by reducing its cost, which now retails for as about $8 per dose. Their study is in ACS’ Organic Letters, a bi-weekly journal…

Read More…

  • Share/Bookmark

Update On Person To Person Spread Of Swine Flu Resistant To Tamiflu, Wales

One additional patient has tested positive for swine flu resistant to Tamiflu at a Cardiff hospital unit. The patient – who was linked with the previous group of five people found to be resistant to Tamiflu last week – was tested as part of the routine screening arrangements introduced at the University Hospital of Wales…

Read More…

  • Share/Bookmark

Publix Pharmacies To Compound Tamiflu Into Oral Suspension

In response to the shortage of Tamiflu in liquid form, all 795 Publix Pharmacies will offer to compound Tamiflu into an oral suspension. Tamiflu, a drug often prescribed to treat flu-like symptoms, is typically available in two forms – capsule or liquid form. The liquid form is generally prescribed to children and adults unable to swallow the capsule form.

Read More…

  • Share/Bookmark

Tamiflu Metabolite Measured In Japanese Sewage Discharge, River Water

In a study published September 24th ahead of print in the peer-reviewed journal Environmental Health Perspectives (EHP), researchers measured oseltamivir carboxylate (OC), the active metabolite of the popular anti-influenza drug Tamiflu (oseltamivir phosphate), in samples of sewage discharge and river water collected near Kyoto City during Japan’s 2008-2009 flu season.

Read More…

  • Share/Bookmark

Walgreens To Compound Tamiflu Oral Suspension For Children In Response To Supply Shortage

Less than a month after launching the largest flu prevention initiative in the company’s 108-year history, Walgreens (NYSE: WAG)(NASDAQ: WAG) is taking proactive measures to ensure its nearly 7,000 pharmacies can provide the suspension – or liquid – form of seasonal flu-fighting drug Tamiflu this season.

Read More…

  • Share/Bookmark

Stanford Research Assesses Use Of Tamiflu, Relenza To Prevent Flu

Two common anti-influenza drugs – Relenza and Tamiflu – appear equally effective at preventing common flu symptoms when given before infection, say researchers from the Stanford University School of Medicine. However, data is lacking on the effectiveness and safety of the two drugs in vulnerable groups such as the very young and people with compromised immune systems.

Read More…

  • Share/Bookmark

Roche To Offer Developing Countries Discounted Tamiflu

The pharmaceutical company Roche on Wednesday announced a program to help ensure developing countries have access to its antiviral Tamiflu, for “the management of a novel influenza strain defined by the WHO as having significant and current pandemic potential,” Reuters reports (Egenter, 7/1).

Read More…

  • Share/Bookmark

Tamiflu-Resistant Flu On The Rise

The type A seasonal flu virus (a subtype of the H1N1 strain) appears to be developing increasing restistance to the most widely used flu drug in the US, Tamiflu (generic name oseltamivir). For the first time, type A viruses were starting to show increased resistance to Tamiflu in the 2007-2008 flu season, but this year the resistance is higher and more widespread.

Read More…

  • Share/Bookmark

Tamiflu Remains Fully Effective Against 94 Percent Of Circulating Influenza Viruses In Europe

Latest surveillance data coming through the European Centre for Disease Prevention and Control (ECDC) from virologists and clinicians indicates that the influenza A(H3N2) virus is the predominant strain in Europe so far this season. Based on the data published by ECDC Roche confirms that the oral antiviral Tamiflu (oseltamivir) is fully active against influenza A(H3N2) and influenza B, which currently comprise 94 percent of circulating viruses in Europe this year.

Read More…

  • Share/Bookmark